Status:
COMPLETED
Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy Subjects
Lead Sponsor:
Amir Abbasnezhad
Collaborating Sponsors:
Lorestan University of Medical Sciences
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-80 years
Brief Summary
In this observational case-control study investigators aimed to assess the serum levels of adipokines such as Apelin, Chemerin and adiponectin in patients with irritable bowel syndrome (IBS), and comp...
Eligibility Criteria
Inclusion
- Men and women between the ages of 18, and 80 years.
- IBS patients diagnosed according to the Rome III Diagnostic Criteria for Functional GI Disorders.
Exclusion
- Any evidence of abdominal surgery or radiation
- celiac disease, or other primary GI illnesses
- GI infection obscuring IBS symptoms,
- using total parenteral nutrition therapy in the last 6 months
- pregnancy and lactation
- alcohol consumption
- concurrent chronic diseases such as diabetes, renal failure
- diagnosed and/or treated malignancy in the past 5 years
- anti-inflammatory drugs usage
- intake of vitamin D, omega-3, vitamin E, and calcium supplements
- being on a special diet or medication regimen during the last 6 months
Key Trial Info
Start Date :
June 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2017
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT03366389
Start Date
June 7 2017
End Date
October 20 2017
Last Update
December 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lorestan university of medical sciences
Khorramabad, Iran